Stockreport

BRIEF-Aclaris Says First Patient Dosed In Pilot Study With ATI-502 Topical [Reuters]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF BRIEF-Aclaris Says First Patient Dosed In Pilot Study With ATI-502 Topical | Reuters Reuters Staff 1 Min Read April 23 (Reuters) - Aclaris Therapeutics Inc: * ACLARIS TH [Read more]